Naturex Raises €48.8m in Capital Increase
As announced a placement in shares corresponding to 319,915 non exercised BSA was conducted on 20 October 2011 and closed on the same day in advance.
Oct 21 2011 --- The capital increase launched by NATUREX on 4 October 2011 met with very high take up by shareholders: 95% of the total number of share warrants (bons de souscription d’actions or BSA) were exercised representing 1,219,857 new shares or a total amount of €46,354,566. This statement includes shares from the exercise of BSA which have been negotiated and exercised during the exercise period from 5 October until 13 October, especially those of Natraceutical which have been reclassified, as disclosed in the press release dated 13 October.
As announced a placement in shares corresponding to 319,915 non exercised BSA was conducted on 20 October 2011 and closed on the same day in advance.
The new shares were placed by CM-CIC Securities and Berenberg Bank, Joint Lead Managers and Bookrunners , at a price of €50.50 per share resulting accordingly in a unit price for the repurchase of unexercised BSA of €2.5.
As a result, gross proceeds raised by NATUREX amounted to €48,785,920.
The success of this capital increase carried out in a difficult market environment highlights shareholders’ interest and confidence in NATUREX and its development project.
The exercise and the listing period for BSA freely allotted on 5 October 2011 was closed on 13 October 2011. After completion of the centralisation process, 95% of the BSA were exercised on the basis of 6,419,200 BSA exercisable after cancellation of 2,540 BSA linked to treasury shares held by the Company on 4 October 2011 and in light of the fact that no stock options were exercised on 12 October 2011.
After shareholders exercised 6,419,200 BSA, the 63,983 new shares issued from the 319,915 BSA unexercised at 13 October 2011 were sold through a placement, after they were repurchased by NATUREX acting as an agent on commission (commissionnaire), by the lead managers and bookrunners for the capital increase.
This placement was closed in advance on 20 October 2011. The new shares were sold through a placement at a price of €50.50 per share resulting accordingly in a unit price for the repurchase of unexercised BSA of €2.5.
This repurchase price will be paid to financial intermediaries maintaining accounts for holders of these BSA repurchased on 26 October 2011, the date for settlement-delivery and the listing of new shares resulting from this capital increase. The new shares will be admitted to trading on Eurolist of NYSE Euronext Paris as of 26 October 2011 under the same ISIN code as existing shares.
Overall, through this capital increase NATUREX was successful in raising gross proceeds of €48,785,920 through the issue of 1,283,840 new shares.
